Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intravenous paracetamol for patent ductus arteriosus in extremely preterm infants
ACTRN12616001517460Phase 2Terminated
- Sponsor
- Timothy Schindler
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in patent ductus arteriosus (PDA) comparing Intravenous paracetamol with Placebo (2 arms). Primary endpoint: Any intervention for management of PDA up to five days. Started Nov 2016; status: terminated.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on ACTRN12616001517460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001517460.